Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatitis C, Chronic | 12 | 2024 | 65 | 1.970 |
Why?
|
| Hepatitis B, Chronic | 5 | 2023 | 27 | 1.480 |
Why?
|
| Hepatitis C | 7 | 2023 | 66 | 1.290 |
Why?
|
| Antiviral Agents | 12 | 2024 | 96 | 1.240 |
Why?
|
| Liver Cirrhosis | 6 | 2024 | 34 | 0.830 |
Why?
|
| Sustained Virologic Response | 6 | 2023 | 17 | 0.770 |
Why?
|
| Humans | 52 | 2024 | 18058 | 0.710 |
Why?
|
| Quality of Life | 4 | 2023 | 509 | 0.670 |
Why?
|
| Female | 41 | 2024 | 12838 | 0.660 |
Why?
|
| Stress, Psychological | 1 | 2020 | 145 | 0.640 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2023 | 26 | 0.610 |
Why?
|
| Hawaii | 12 | 2023 | 45 | 0.600 |
Why?
|
| Health Status | 1 | 2020 | 331 | 0.600 |
Why?
|
| Suicide | 3 | 2024 | 126 | 0.590 |
Why?
|
| Liver Neoplasms | 3 | 2023 | 42 | 0.590 |
Why?
|
| Male | 27 | 2024 | 10173 | 0.520 |
Why?
|
| Hepacivirus | 9 | 2024 | 51 | 0.520 |
Why?
|
| Mental Disorders | 3 | 2022 | 290 | 0.480 |
Why?
|
| Patient Health Questionnaire | 2 | 2024 | 18 | 0.470 |
Why?
|
| Adult | 21 | 2024 | 7696 | 0.470 |
Why?
|
| Middle Aged | 23 | 2024 | 8073 | 0.460 |
Why?
|
| Cataract Extraction | 1 | 2012 | 3 | 0.420 |
Why?
|
| Cataract | 1 | 2012 | 10 | 0.420 |
Why?
|
| Rural Population | 1 | 2012 | 48 | 0.410 |
Why?
|
| Adolescent | 20 | 2024 | 3714 | 0.400 |
Why?
|
| United States | 13 | 2024 | 4119 | 0.390 |
Why?
|
| Prevalence | 5 | 2023 | 892 | 0.380 |
Why?
|
| Aged | 15 | 2024 | 6258 | 0.380 |
Why?
|
| Coinfection | 2 | 2023 | 30 | 0.370 |
Why?
|
| Hepatitis B | 2 | 2023 | 43 | 0.370 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 2 | 2022 | 4 | 0.360 |
Why?
|
| Mental Health | 2 | 2023 | 166 | 0.360 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 2 | 2007 | 4 | 0.350 |
Why?
|
| Risk Factors | 10 | 2022 | 3394 | 0.350 |
Why?
|
| Diet | 3 | 2007 | 359 | 0.340 |
Why?
|
| Lung Neoplasms | 2 | 2024 | 257 | 0.340 |
Why?
|
| Retrospective Studies | 8 | 2024 | 2498 | 0.330 |
Why?
|
| Absorptiometry, Photon | 4 | 2011 | 59 | 0.310 |
Why?
|
| Cohort Studies | 12 | 2024 | 2631 | 0.300 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2019 | 742 | 0.290 |
Why?
|
| Self-Injurious Behavior | 2 | 2024 | 45 | 0.290 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2006 | 7 | 0.270 |
Why?
|
| Feeding Behavior | 2 | 2007 | 165 | 0.270 |
Why?
|
| Breast Neoplasms | 5 | 2017 | 1023 | 0.260 |
Why?
|
| Hepatitis B virus | 3 | 2023 | 21 | 0.260 |
Why?
|
| Clozapine | 1 | 2024 | 5 | 0.240 |
Why?
|
| Aminoisobutyric Acids | 1 | 2024 | 2 | 0.240 |
Why?
|
| Cyclopropanes | 1 | 2024 | 2 | 0.240 |
Why?
|
| Lactams, Macrocyclic | 1 | 2024 | 2 | 0.240 |
Why?
|
| Leucine | 1 | 2024 | 3 | 0.240 |
Why?
|
| Benzimidazoles | 1 | 2024 | 6 | 0.240 |
Why?
|
| Proline | 1 | 2024 | 5 | 0.240 |
Why?
|
| Sulfonamides | 1 | 2024 | 15 | 0.240 |
Why?
|
| Body Mass Index | 4 | 2022 | 961 | 0.240 |
Why?
|
| Adipose Tissue | 5 | 2011 | 59 | 0.240 |
Why?
|
| Obesity | 3 | 2024 | 839 | 0.230 |
Why?
|
| Psychotic Disorders | 1 | 2024 | 47 | 0.230 |
Why?
|
| Antipsychotic Agents | 1 | 2024 | 57 | 0.230 |
Why?
|
| ras Proteins | 2 | 2014 | 24 | 0.230 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2014 | 36 | 0.230 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2023 | 10 | 0.220 |
Why?
|
| Latent Tuberculosis | 1 | 2023 | 10 | 0.220 |
Why?
|
| Opportunistic Infections | 1 | 2022 | 7 | 0.220 |
Why?
|
| Ribavirin | 2 | 2019 | 9 | 0.210 |
Why?
|
| African Americans | 3 | 2020 | 485 | 0.210 |
Why?
|
| Breast | 3 | 2011 | 85 | 0.210 |
Why?
|
| Carbonated Beverages | 3 | 2007 | 14 | 0.200 |
Why?
|
| Pregnancy Outcome | 1 | 2022 | 158 | 0.200 |
Why?
|
| Multivariate Analysis | 3 | 2020 | 595 | 0.190 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 205 | 0.190 |
Why?
|
| Surveys and Questionnaires | 4 | 2022 | 1346 | 0.190 |
Why?
|
| Health Services Accessibility | 2 | 2021 | 316 | 0.190 |
Why?
|
| Weight Gain | 1 | 2022 | 180 | 0.190 |
Why?
|
| Young Adult | 7 | 2024 | 2479 | 0.180 |
Why?
|
| Psychology | 1 | 2020 | 17 | 0.180 |
Why?
|
| Autism Spectrum Disorder | 1 | 2023 | 155 | 0.180 |
Why?
|
| Cholagogues and Choleretics | 1 | 2020 | 2 | 0.180 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2020 | 2 | 0.180 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2020 | 2 | 0.180 |
Why?
|
| Overweight | 1 | 2022 | 272 | 0.180 |
Why?
|
| Unemployment | 1 | 2020 | 10 | 0.180 |
Why?
|
| Psychiatry | 1 | 2020 | 22 | 0.180 |
Why?
|
| Physician's Role | 1 | 2020 | 33 | 0.180 |
Why?
|
| Delayed Diagnosis | 1 | 2019 | 20 | 0.170 |
Why?
|
| Incidence | 5 | 2022 | 1297 | 0.170 |
Why?
|
| Puberty | 2 | 2011 | 58 | 0.160 |
Why?
|
| China | 2 | 2024 | 126 | 0.160 |
Why?
|
| Prospective Studies | 5 | 2023 | 1294 | 0.160 |
Why?
|
| Treatment Outcome | 5 | 2024 | 1259 | 0.160 |
Why?
|
| Social Support | 1 | 2020 | 211 | 0.160 |
Why?
|
| Virus Activation | 1 | 2018 | 6 | 0.160 |
Why?
|
| Mental Health Services | 1 | 2020 | 159 | 0.160 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 56 | 0.160 |
Why?
|
| Time Factors | 5 | 2019 | 1114 | 0.150 |
Why?
|
| Comorbidity | 1 | 2020 | 618 | 0.150 |
Why?
|
| Neoplasms | 1 | 2022 | 464 | 0.150 |
Why?
|
| Liver | 1 | 2017 | 33 | 0.150 |
Why?
|
| Gene Library | 1 | 2017 | 3 | 0.150 |
Why?
|
| Paraffin Embedding | 1 | 2017 | 6 | 0.150 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 613 | 0.150 |
Why?
|
| Child | 8 | 2023 | 2519 | 0.150 |
Why?
|
| Calcium, Dietary | 3 | 2007 | 30 | 0.150 |
Why?
|
| Risk Assessment | 5 | 2024 | 1137 | 0.150 |
Why?
|
| Suicidal Ideation | 3 | 2024 | 102 | 0.150 |
Why?
|
| Pregnancy | 1 | 2022 | 1484 | 0.150 |
Why?
|
| MicroRNAs | 1 | 2017 | 17 | 0.150 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 38 | 0.150 |
Why?
|
| Suicide, Attempted | 1 | 2018 | 98 | 0.150 |
Why?
|
| Tuberculosis | 1 | 2017 | 17 | 0.150 |
Why?
|
| Health Policy | 1 | 2018 | 135 | 0.150 |
Why?
|
| Menarche | 2 | 2009 | 30 | 0.140 |
Why?
|
| Colorectal Neoplasms | 2 | 2014 | 643 | 0.140 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 397 | 0.140 |
Why?
|
| Viral Load | 1 | 2017 | 132 | 0.140 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2017 | 57 | 0.140 |
Why?
|
| Population Surveillance | 1 | 2018 | 270 | 0.140 |
Why?
|
| Sex Distribution | 2 | 2017 | 192 | 0.140 |
Why?
|
| Age Distribution | 2 | 2017 | 257 | 0.140 |
Why?
|
| Cross-Sectional Studies | 5 | 2024 | 1309 | 0.130 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 1956 | 0.120 |
Why?
|
| Cause of Death | 3 | 2021 | 181 | 0.120 |
Why?
|
| ErbB Receptors | 1 | 2012 | 7 | 0.110 |
Why?
|
| Age Factors | 4 | 2019 | 945 | 0.110 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 7 | 0.110 |
Why?
|
| Medication Adherence | 1 | 2015 | 255 | 0.100 |
Why?
|
| Skinfold Thickness | 3 | 2006 | 18 | 0.100 |
Why?
|
| Minority Groups | 2 | 2023 | 103 | 0.100 |
Why?
|
| Analysis of Variance | 2 | 2012 | 162 | 0.090 |
Why?
|
| Prognosis | 3 | 2020 | 619 | 0.090 |
Why?
|
| Iron, Dietary | 2 | 2007 | 7 | 0.090 |
Why?
|
| Heart Failure | 1 | 2015 | 391 | 0.090 |
Why?
|
| Dietary Fiber | 2 | 2007 | 59 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2022 | 1164 | 0.090 |
Why?
|
| Depression | 2 | 2024 | 512 | 0.080 |
Why?
|
| Asian Americans | 2 | 2020 | 184 | 0.080 |
Why?
|
| Nutritional Requirements | 1 | 2007 | 6 | 0.080 |
Why?
|
| Body Fat Distribution | 1 | 2007 | 5 | 0.080 |
Why?
|
| Dietary Sucrose | 1 | 2007 | 12 | 0.080 |
Why?
|
| Nutrition Policy | 1 | 2007 | 18 | 0.070 |
Why?
|
| Skin | 1 | 2007 | 14 | 0.070 |
Why?
|
| Sunlight | 1 | 2007 | 16 | 0.070 |
Why?
|
| Vitamin D Deficiency | 1 | 2007 | 21 | 0.070 |
Why?
|
| Vitamin D | 1 | 2007 | 78 | 0.070 |
Why?
|
| Asia | 1 | 2006 | 15 | 0.070 |
Why?
|
| Survival Rate | 2 | 2020 | 266 | 0.070 |
Why?
|
| Folic Acid | 1 | 2006 | 35 | 0.070 |
Why?
|
| Diet Surveys | 1 | 2006 | 57 | 0.070 |
Why?
|
| European Continental Ancestry Group | 2 | 2020 | 559 | 0.070 |
Why?
|
| Smoking | 2 | 2022 | 465 | 0.070 |
Why?
|
| California | 2 | 2023 | 2327 | 0.060 |
Why?
|
| Milk | 1 | 2004 | 8 | 0.060 |
Why?
|
| Smoke | 1 | 2024 | 5 | 0.060 |
Why?
|
| Pyrrolidines | 1 | 2024 | 2 | 0.060 |
Why?
|
| Longitudinal Studies | 3 | 2018 | 705 | 0.060 |
Why?
|
| Pruritus | 1 | 2023 | 3 | 0.060 |
Why?
|
| Quinoxalines | 1 | 2024 | 12 | 0.060 |
Why?
|
| Bone Density | 1 | 2004 | 98 | 0.060 |
Why?
|
| Infant Formula | 1 | 2003 | 11 | 0.060 |
Why?
|
| Fatigue | 1 | 2023 | 35 | 0.060 |
Why?
|
| Schizophrenia | 1 | 2024 | 80 | 0.060 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2014 | 25 | 0.060 |
Why?
|
| Genotype | 1 | 2024 | 251 | 0.060 |
Why?
|
| Logistic Models | 2 | 2019 | 953 | 0.060 |
Why?
|
| Population Groups | 1 | 2023 | 8 | 0.060 |
Why?
|
| Proportional Hazards Models | 2 | 2020 | 745 | 0.060 |
Why?
|
| Body Weight | 1 | 2004 | 216 | 0.060 |
Why?
|
| Mutation | 2 | 2014 | 129 | 0.060 |
Why?
|
| Health Promotion | 1 | 2006 | 295 | 0.050 |
Why?
|
| Exercise | 2 | 2004 | 478 | 0.050 |
Why?
|
| Genetic Testing | 2 | 2014 | 89 | 0.050 |
Why?
|
| Child Health | 1 | 2023 | 30 | 0.050 |
Why?
|
| Nontuberculous Mycobacteria | 1 | 2022 | 2 | 0.050 |
Why?
|
| Regression Analysis | 3 | 2007 | 319 | 0.050 |
Why?
|
| Liver Transplantation | 1 | 2020 | 7 | 0.050 |
Why?
|
| Aspartate Aminotransferases | 1 | 2020 | 14 | 0.050 |
Why?
|
| Alanine Transaminase | 1 | 2020 | 22 | 0.050 |
Why?
|
| Bilirubin | 1 | 2020 | 30 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2020 | 69 | 0.040 |
Why?
|
| Oceanic Ancestry Group | 1 | 2020 | 34 | 0.040 |
Why?
|
| Health Surveys | 1 | 2020 | 266 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2019 | 62 | 0.040 |
Why?
|
| Mammography | 2 | 2011 | 173 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 118 | 0.040 |
Why?
|
| Interferons | 1 | 2019 | 5 | 0.040 |
Why?
|
| Washington | 1 | 2020 | 384 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2019 | 45 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2020 | 692 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2023 | 1428 | 0.040 |
Why?
|
| Hospitalization | 1 | 2024 | 813 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2018 | 49 | 0.040 |
Why?
|
| Glycated Hemoglobin A | 1 | 2019 | 231 | 0.040 |
Why?
|
| Fibrosis | 1 | 2017 | 7 | 0.040 |
Why?
|
| Risk-Taking | 1 | 2018 | 113 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2017 | 4 | 0.040 |
Why?
|
| Hispanic Americans | 1 | 2020 | 431 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2017 | 32 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2019 | 344 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2018 | 162 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 667 | 0.040 |
Why?
|
| Ethnic Groups | 1 | 2020 | 504 | 0.030 |
Why?
|
| Biomarkers | 1 | 2017 | 306 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 1255 | 0.030 |
Why?
|
| Body Composition | 2 | 2007 | 80 | 0.030 |
Why?
|
| Health Behavior | 1 | 2018 | 379 | 0.030 |
Why?
|
| Pacific States | 1 | 2015 | 2 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 634 | 0.030 |
Why?
|
| Educational Status | 1 | 2015 | 205 | 0.030 |
Why?
|
| Mass Screening | 1 | 2020 | 678 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 32 | 0.030 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2015 | 54 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 94 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 147 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 330 | 0.030 |
Why?
|
| Continental Population Groups | 1 | 2015 | 317 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2019 | 843 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 97 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 129 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 57 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2012 | 249 | 0.030 |
Why?
|
| Family Health | 1 | 2011 | 47 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2011 | 235 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 318 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2012 | 248 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 394 | 0.020 |
Why?
|
| Mothers | 1 | 2011 | 110 | 0.020 |
Why?
|
| Polynesia | 1 | 2009 | 1 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2007 | 23 | 0.020 |
Why?
|
| Dietary Proteins | 1 | 2007 | 19 | 0.020 |
Why?
|
| Dietary Carbohydrates | 1 | 2007 | 27 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 50 | 0.020 |
Why?
|
| Diet Records | 1 | 2007 | 32 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2007 | 8 | 0.020 |
Why?
|
| Energy Intake | 1 | 2007 | 100 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2007 | 90 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2007 | 108 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2004 | 65 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2004 | 92 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 46 | 0.010 |
Why?
|
| Animals | 1 | 2004 | 250 | 0.010 |
Why?
|
| Anthropometry | 1 | 2003 | 63 | 0.010 |
Why?
|
| Aging | 1 | 2003 | 159 | 0.010 |
Why?
|
| Breast Feeding | 1 | 2003 | 134 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2003 | 852 | 0.010 |
Why?
|
Concepts
(243)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->